期刊文献+

血清IL-35在病毒感染致心肌炎患者中治疗前后的变化研究 被引量:6

Changes of serum IL-35 in patients with myocarditis induced by virus infection before and after treatment
原文传递
导出
摘要 目的探讨血清白细胞介素-35(IL-35)在病毒感染致心肌炎患者中治疗前后的变化。方法选取2012年2月-2016年2月医院收治的68例病毒性心肌炎患者为试验组。另选取同期健康体检的健康人群70例为对照组。采集研究对象静脉血检测病毒,检测肌酸激酶同工酶(CK-MB)、肌钙蛋白I(cTn I)、IL-17、IL-35和干扰素-γ(IFN-γ)。结果 68例病毒性心肌炎患者中共检出68株病毒,其中RNA病毒41株占60.29%,DNA病毒27株占39.71%。检出前三位的病毒是柯萨奇病毒B、柯萨奇病毒A和疱疹病毒I型。68例病毒性心肌炎治愈15例,显效35例,有效16例,无效2例,总有效率为97.06%(66/68)。试验组血清IL-17、CK-MB、cTn I和IFN-γ水平分别为(512.75±38.29)pg/ml、(33.55±6.31)U/ml、(0.50±0.22)μg/ml和(1368.62±715.28)ng/L均高于对照组(P<0.05),血清IL-35为(192.52±29.35)ng/ml低于对照组(P<0.05)。试验组患者治疗后血清IL-17、CK-MB、cTn I和IFN-γ水平均降低,血清IL-35水平升高(P均<0.05)。不同预后患者治疗前IL-35水平差异有统计学意义(P=0.010)。结论 IL-35在病毒性心肌炎的发生、发展过程中具有重要作用,其基线水平的高低可作为病毒性心肌炎预后判断的重要指标之一。 OBJECTIVE To investigate the changes of serum interleukin-35(IL-35)in patients with myocarditis caused by viral infection before and after treatment.METHODS From Feb.2012 to Feb.2016,68 patients with viral myocarditis were treated as observation group.In addition,70 healthy people were selected as control group.Venous blood of patients were collected for detection of virus,and creatine kinase isoenzyme(CK-MB),troponin I(cTn I),IL-17,IL-35 and interferon-γ(IFN-γ)were measured.RESULTS Sixty-eight viruses were detected in68 patients with viral myocarditis.Among them,41 were RNA viruses,accounting for 60.29%,and 27 were DNA viruses,accounting for 39.71%.The top three viruses were Coxsackie virus B,Coxsackie virus A and herpes virus type I.Among 68 cases of viral myocarditis,15 cases were cured,35 cases were markedly effective,16 cases were effective,and 2 cases were non-effective,and the total effective rate was 97.06%(66/68).The levels of serum IL-17,CK-MB,cTn I and IFN-γin the observation group were(512.75±38.29)pg/ml,(33.55±6.31)U/ml,(0.50±0.22)μg/ml and(1368.62±715.28)ng/L,which were significantly higher than those in the control group(P〈0.05),and the level of serum IL-35 was(192.52±29.35)ng/ml,which was significantly lower than that of the control group(P〈0.05).The levels of serum IL-17,CK-MB,cTn I and IFN-γwere significantly decreased(P〈0.05),and the serum IL-35 level was significantly increased(P〈0.05)in the observation group after treatment.There were significant differences in IL-35 levels between patients with different prognostic viral myocarditis before treatment(P=0.010).CONCLUSIONIL-35 plays an important role in the development and progression of viral myocarditis,and its baseline level can be used as one of the important indexes to judge the prognosis of viral myocarditis.
作者 张腊喜 严江涛 陈泽江 龙吴坚 刘正湘 ZHANG La-xi;YAN Jiang-tao;CHEN Ze-jiang;LONG Wu-jian;LIU Zheng-xiang(Wenchang City People's Hospital, Wenchang, Hainan, 571300, China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2018年第11期1637-1640,共4页 Chinese Journal of Nosocomiology
基金 海南省医药卫生科研基金资助项目(15A200045)
关键词 病毒性心肌炎 白细胞介素-35 预后 感染 Viral myocarditis IL-35 Prognosis Infection
  • 相关文献

参考文献4

二级参考文献26

  • 1世界卫生组织及国际心脏病学会工作组.成人急性病毒性心肌炎诊断参考标准.中国循环杂志,2001,8(14):307-307.
  • 2Ohshima M, Yamahara K, Ishikane S, et al. Systemic transplanta- tion of allogenic fetal membrane-derived mesenchymal stem ceils suppresses Thl and Thl7 T cell responses in experimental autoim- nmne myocarditis[ J]. J Mol Cell Cardiol, 2012,53 (3) :420-428.
  • 3Wang RX, Yu CR, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease [ J]. Nat Med, 2014, 20(6) :633-641.
  • 4Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis [J]. J Am Coil Cardiol, 2012,59(9) :779-792.
  • 5Xie Y, Chen R, Zhang X, et al. The role of Thl7 cells and regu- latory T cells in Coxsackievirus B3-induced myocarditis[ J]. Viral- ogy, 2011,1421 ( 1 ) :78-84.
  • 6Sonderegger I, Rtihn TA, Kurrer MO, et al. Neutralization of IL- 17 by active vaccination inhibits IL-23-dependent autoimmune myo-carditis[ J]. Eur J Immunol, 2006,36 ( 11 ) :2849-2856.
  • 7Yuan J, Yu M, Lin QW, et al. Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis [J]. Int hnmunopharmacol, 2010,10 (3) :272-276.
  • 8Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37 : the ex- panding spectrum of anti-inflammatory cytokines [ J ]. Nat Immu- nol, 2012,13(10) :925-931.
  • 9Matsui Y, Inobe M, Okamoto H, et al. Blockade of T cell costim- ulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis[ J]. J Mol Cell Cardiol, 2012,34(3) :279-295.
  • 10Ye S, Wu J, Zhou L, et al. Interleukin-35 : the future of hyperim- mune-related diseases [J]. J Interferon Cytokine Res, 2013,33 (6) :285-291.

共引文献62

同被引文献53

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部